|
1
|
Claus EB, Bondy ML, Schildkraut JM,
Wiemels JL, Wrensch M and Black PM: Epidemiology of intracranial
meningioma. Neurosurgery. 57:1088–1095. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pasquier D, Bijmolt S, Veninga T, et al:
Atypical and malignant meningioma: outcome and prognostic factors
in 119 irradiated patients. A multicenter, retrospective study of
the Rare Cancer Network. Int J Radiat Oncol Biol Phys.
71:1388–1393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Linsler S, Kraemer D, Driess C, et al:
Molecular biological determinations of meningioma progression and
recurrence. PloS One. 9:e949872014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Konstantinopoulos PA, Spentzos D and
Cannistra SA: Gene-expression profiling in epithelial ovarian
cancer. Nat Clin Pract Oncol. 5:577–587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van ‘t Veer LJ, Dai H, van de Vijver MJ,
et al: Gene expression profiling predicts clinical outcome of
breast cancer. Nature. 415:530–536. 2002. View Article : Google Scholar
|
|
6
|
Motoori M, Takemasa I, Yano M, et al:
Prediction of recurrence in advanced gastric cancer patients after
curative resection by gene expression profiling. Int J Cancer.
114:963–968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen HY, Yu SL, Chen CH, et al: A
five-gene signature and clinical outcome in non-small-cell lung
cancer. N Engl J Med. 356:11–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schramm A, Schulte JH, Klein-Hitpass L, et
al: Prediction of clinical outcome and biological characterization
of neuroblastoma by expression profiling. Oncogene. 24:7902–7912.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tabernero MD, Maillo A, Gil-Bellosta CJ,
et al: Gene expression profiles of meningiomas are associated with
tumor cytogenetics and patient outcome. Brain Pathol. 19:409–420.
2009. View Article : Google Scholar
|
|
10
|
Lee Y, Liu J, Patel S, et al: Genomic
landscape of meningiomas. Brain Pathol. 20:751–762. 2010.
View Article : Google Scholar
|
|
11
|
Wu Z, Irizarry RA, Gentleman R,
Martinez-Murillo F and Spencer F: A model-based background
adjustment for oligonucleotide expression arrays. J Am Stat Assoc.
99:909–917. 2004. View Article : Google Scholar
|
|
12
|
Irizarry RA, Hobbs B, Collin F, et al:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smyth GK: Limma: linear models for
microarray data. Bioinformatics and Computational Biology Solutions
Using R and Bioconductor. Springer; New York: pp. 397–420. 2005,
View Article : Google Scholar
|
|
14
|
Therneau TM and Grambsch PM: Modeling
Survival Data: Extending the Cox Model. Springer; New York:
2000
|
|
15
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gordon GJ, Bueno R and Sugarbaker DJ:
Genes associated with prognosis after surgery for malignant pleural
mesothelioma promote tumor cell survival in vitro. BMC Cancer.
11:1692011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gordon GJ, Dong L, Yeap BY, et al:
Four-gene expression ratio test for survival in patients undergoing
surgery for mesothelioma. J Natl Cancer Inst. 101:678–686. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Wang H, Jin X and Zhao L: Loss of
RhoGDI is a novel independent prognostic factor in hepatocellular
carcinoma. Int J Clin Exp Pathol. 6:2535–2541. 2013.PubMed/NCBI
|
|
19
|
Douds JJ, Long DJ, Kim AS and Li S:
Diagnostic and prognostic significance of CD200 expression and its
stability in plasma cell myeloma. J Clin Pathol. 67:792–796. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alapat D, Coviello-Malle J, Owens R, et
al: Diagnostic usefulness and prognostic impact of CD200 expression
in lymphoid malignancies and plasma cell myeloma. Am J Clin Pathol.
137:93–100. 2012. View Article : Google Scholar
|
|
21
|
Tonks A, Hills R, White P, et al: CD200 as
a prognostic factor in acute myeloid leukaemia. Leukemia.
21:566–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Caizzi L, Ferrero G, Cutrupi S, et al:
Genome-wide activity of unliganded estrogen receptor-alpha in
breast cancer cells. Proc Natl Acad Sci USA. 111:4892–4897. 2014.
View Article : Google Scholar
|
|
23
|
Gao QG, Chan HY, Man CW and Wong MS:
Differential ERalpha-mediated rapid estrogenic actions of
ginsenoside Rg1 and estren in human breast cancer MCF-7 cells. J
Steroid Biochem Mol Biol. 141:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martinez-Galan J, Torres-Torres B, Nunez
MI, et al: ESR1 gene promoter region methylation in free
circulating DNA and its correlation with estrogen receptor protein
expression in tumor tissue in breast cancer patients. BMC Cancer.
14:592014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Toy W, Shen Y, Won H, et al: ESR1
ligand-binding domain mutations in hormone-resistant breast cancer.
Nat Genet. 45:1439–1445. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu Z, Wang G and Chen W: Estrogen receptor
alpha gene polymorphisms and risk of prostate cancer: a
meta-analysis involving 18 studies. Tumour Biol. 35:5921–5930.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Atmaca A, Al-Batran SE, Wirtz RM, et al:
The validation of estrogen receptor 1 mRNA expression as a
predictor of outcome in patients with metastatic non-small cell
lung cancer. Int J Cancer. 134:2314–2321. 2014. View Article : Google Scholar
|
